Short Interest in Ocean Biomedical, Inc. (NASDAQ:OCEAW) Rises By 250.0%

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large growth in short interest in October. As of October 15th, there was short interest totalling 8,400 shares, a growth of 250.0% from the September 30th total of 2,400 shares. Based on an average daily volume of 48,900 shares, the days-to-cover ratio is presently 0.2 days.

Ocean Biomedical Stock Down 25.9 %

OCEAW traded down $0.01 during trading on Friday, reaching $0.04. 8,498 shares of the company’s stock were exchanged, compared to its average volume of 43,124. The business has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.06. Ocean Biomedical has a fifty-two week low of $0.02 and a fifty-two week high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.